Champions Oncology
CSBR
31 hedge funds and large institutions have $51.7M invested in Champions Oncology in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 8 closing their positions.
0.88% less ownership
Funds ownership: 46.78% → 45.91% (-0.88%)
11% less funds holding
Funds holding: 35 → 31 (-4)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
19% less capital invested
Capital invested by funds: $64.1M → $51.7M (-$12.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$765K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$156K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$143K |
| 4 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
+$36.8K |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.02M |
| 2 |
E
Ergoteles
New York
|
-$312K |
| 3 |
Renaissance Technologies
New York
|
-$280K |
| 4 |
HF
HRT Financial
New York
|
-$128K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$85.5K |
CSBR Hedge Fund Activity: Q4 2021 in Review
31 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q4 2021, worth a combined $51.7M — down 19% from $64.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CSBR and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Ameriprise, opening a new position worth an estimated $765K. The largest seller was Bank of Montreal, exiting entirely with an estimated $1.02M sold.
- 31 institutional investors held Champions Oncology (CSBR) as of Q4 2021, down from 35 in Q3 2021.
- Funds reported $51.7M of Champions Oncology stock for Q4 2021, down 19% quarter-over-quarter.
- 4 funds opened new Champions Oncology positions in Q4 2021 and 8 closed out, a net change of -4 holders.
- The largest Champions Oncology buyer in Q4 2021 was Ameriprise, an estimated $765K added.
- The largest Champions Oncology seller in Q4 2021 was Bank of Montreal, an estimated $1.02M sold.
Based on aggregated 13F filings for Q4 2021.